Anthropic using Claude to discover a novel CRISPR-like enzyme system in bacteriophages marks the pivot from chat wrappers to automated biotech IP. With inference costs dropping 40% per model cycle, basic text generation cannot justify multi-trillion dollar valuations. Committing $1B to safety red-teaming is regulatory PR while Anthropic builds an automated bio-discovery engine. Finding uncharacterized genomic structures proves frontier labs are moving into synthetic biology and drug discovery, where proprietary patents create actual defensive moats against open-weight models. https://t.co/soeBRGb6Z4
Murtuza J MerchantShare
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.